Your session is about to expire
← Back to Search
Virtual Group Speech Therapy for Head and Neck Cancer
Phase 1 & 2
Waitlist Available
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 weeks post radiation
Awards & highlights
Summary
This trial will study how a virtual, group-based therapy, with a patient partner, can improve care for head and neck cancer patients.
Who is the study for?
Adults over 18 with head or neck cancer starting chemoradiotherapy for cure can join. They need a radiation dose of at least 60 Grays and must speak French well enough for questionnaires. Those with distant cancer spread, planned total laryngectomy, prior severe swallowing issues, another simultaneous cancer, previous head/neck radiation, or significant cognitive impairments cannot participate.
What is being tested?
The trial is testing the eG2 Intervention: a virtual group speech therapy guided by a patient partner to prevent swallowing difficulties in patients undergoing chemoradiotherapy for head and neck cancers. It aims to improve care quality and accessibility while optimizing healthcare resources.
What are the potential side effects?
Since this intervention involves speech therapy rather than medication, typical drug side effects are not expected. However, participants may experience fatigue from regular sessions or stress from technology use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 weeks post radiation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 weeks post radiation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rate of nasogastric tube
Trial Design
1Treatment groups
Experimental Treatment
Group I: virtual group speech therapy intervention guided by a patient partnerExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
372 Previous Clinical Trials
130,955 Total Patients Enrolled
Université du Québec à Trois-RivièresOTHER
47 Previous Clinical Trials
4,443 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My radiation therapy is planned to be 60 Grays or more.I have had serious swallowing problems checked by a speech therapist.I have been diagnosed with another cancer at the same time as my current one.I am 18 or older with head or neck cancer.I am scheduled for chemoradiotherapy aimed at curing my condition.I can complete questionnaires in French well.I have had radiation therapy to my head or neck.I have or might have a cognitive issue that could affect my participation in the study.My cancer has spread to distant parts of my body.I have had or will have my voice box removed.
Research Study Groups:
This trial has the following groups:- Group 1: virtual group speech therapy intervention guided by a patient partner
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger